Guggenheim Capital LLC Verastem, Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $31,556 - $94,997	-10,957 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.92 - $3.81 $686 - $895	-235 Reduced 2.1%	10,957 $33,000
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $4,180 - $6,780	-1,398 Reduced 11.1%	11,192 $34,000
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $37,895 - $68,111	12,590	12,590 $59,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $880M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.